008 |
|
200111s2020 enk o 001 0 eng d |
020 |
|
|a9780128220276
|
020 |
|
|a0128220279
|
020 |
|
|a9780128194942 (print)
|
020 |
|
|a0128194944
|
040 |
|
|aEBLCP|beng|epn|cEBLCP|dOPELS|dOCLCF|dUKAHL|dOCLCQ|dYDX|dUKMGB|dESU
|
041 |
0
|
|aeng
|
050 |
4
|
|aRC269
|
082 |
04
|
|a616.99/407|223
|
095 |
|
|aNF|tLCC|p|dRC269|e|c
|
245 |
00
|
|aTumor vascularization|h[electronic resource] /|cedited by Domenico Ribatti and Francesco Pezzella.
|
260 |
|
|aLondon :|bAcademic Press,|c2020.
|
300 |
|
|a1 online resource (200 p.)
|
500 |
|
|aLong noncoding RNAs pathway
|
500 |
|
|aIncludes index.
|
505 |
0
|
|aFront Cover -- Tumor Vascularization -- Copyright Page -- Contents -- List of contributors -- Preface -- 1 Sprouting and nonsprouting angiogenesis in tumors -- Introduction -- The angiogenic switch -- Sprouting tumor angiogenesis -- Intussusceptive microvascular growth angiogenesis -- Glomeruloid vascular proliferation -- Concluding remarks -- References -- 2 Nonangiogenic tumor growth -- Introduction -- Identification of nonangiogenic tumors -- Alveolar growth pattern -- Lepidic growth pattern -- Interstitial growth pattern -- Perivascular (cuffing) growth pattern
|
505 |
8
|
|aThe biology of nonangiogenic growth -- Hypoxia and angiogenesis -- Inflammation and immune response -- Motility, invasion, and cell-cell adhesion -- Energy metabolism -- What causes tumors to grow in an angiogenic or nonangiogenic, vessel co-opting way? -- Blood vessels change when they are co-opted by malignant cells -- Conclusion -- References -- 3 Vascular co-option -- Vascular co-option in normal and transformed cells -- Vascular co-option in non-cancer cells -- Vascular co-option in cancer cells -- Molecular regulation of vascular co-option
|
505 |
8
|
|aMolecular regulation of cell adhesion and proliferation in vascular co-option -- Molecular regulation of migration and invasion linked to vascular co-option -- Molecular regulation of dormancy, latency, and awakening linked to vascular co-option -- Preclinical applications to target vascular co-option: prevention of metastasis -- Acknowledgments -- References -- 4 Pericyte mimicry: an embryogenesis-derived program of extravascular tumor cell migration -- Introduction -- Interactions between tumor cells and blood vessels -- History -- Angiotropism, PM and EVMM -- PM in melanoma -- Histopathology
|
505 |
8
|
|aHistological criteria -- Melanoma liver metastases -- Experimental models of PM -- Prognostic significance of angiotropism and PM -- Molecular findings -- Angiotropism, PM, and EVMM in non-melanoma tumors -- Molecular studies -- Laminin and cancer cell migration -- Laminins in melanoma -- Laminins in non-melanoma tumors -- Modulation of laminins in embryogenesis and in cancer progression -- PM and EVMM: Reversion to an embryogenesis-derived program -- Analogies between embryogenesis and cancer development -- Neural crest cell migration: a model for PM/EVMM -- Angiogenesis -- Cell competition
|
505 |
8
|
|aPM and EVMM: routes, direction and timing according to an embryogenesis-derived program -- Space, direction, and timing -- Perspectives and therapeutic implications -- Detection of PM and EVMM -- Therapeutic perspectives -- DAN -- YAP signaling -- Laminins -- Concluding remarks -- PM and vascular co-option: complementary embryonic phenomena? -- Acknowledgments -- References -- 5 Vasculogenic mimicry -- Introduction -- Vasculogenic mimicry in prognosis and progress -- Molecular pathway of vasculogenic mimicry -- Hypoxia/hypoxia-inducible factor pathway -- Vascular endothelial-cadherin pathway
|
588 |
0
|
|aPrint version record.
|
650 |
0
|
|aTumors|xBlood-vessels.
|
650 |
7
|
|aTumors|xBlood-vessels.|2fast|0(OCoLC)fst01158762
|
655 |
4
|
|aElectronic books.
|
700 |
1
|
|aRibatti, Domenico,|d1956-
|
700 |
1
|
|aPezzella, Francesco.
|
856 |
40
|
|uhttps://www.sciencedirect.com/science/book/9780128194942
|